2015-2019 French HIV/AIDS Diagnostic Testing Market: Emerging Opportunities and Growth Strategies
Complete report $2,300. DataPack (test volumes, sales forecasts, supplier shares) $1,500.
Summary
This report presents detailed analyses of the AIDS diagnostics market in France.
The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 250 pages and 7 tables
Summary
This report presents detailed analyses of the AIDS diagnostics market in France.
The report provides test volume and sales forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho-Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
The report is based on a combination of primary and secondary information sources, including VPGMarketResearchs proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Contains 250 pages and 7 tables
I. INTRODUCTION
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatch
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Background
B. Diagnostic Tests: HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies
III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES
IV. ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
V. POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VI. COMPETITIVE ASSESSMENTS
Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix
DiaSorin
Eiken Chemical
Enzo Biochem
Fujirebio/Innogenetics
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatch
Life Technology
Lonza
Nanogen/Elitech
Novartis Diagnostics
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako
LIST OF TABLES
Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. France: HIV or HIV-1/2 Test Volume and Sales Forecast by Market Segment
Table 3. France: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. France: Western Blot/Other Confirmatory Tests Volume and Sales Forecast by Market Segment
Table 5. France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. France: AIDS Diagnostics Market by Major Supplier
Table 7. France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Table 1. Major Companies Developing or Marketing AIDS Tests
Table 2. France: HIV or HIV-1/2 Test Volume and Sales Forecast by Market Segment
Table 3. France: HIV Ag Test Volume and Sales Forecast by Market Segment
Table 4. France: Western Blot/Other Confirmatory Tests Volume and Sales Forecast by Market Segment
Table 5. France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Table 6. France: AIDS Diagnostics Market by Major Supplier
Table 7. France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers